IP Verse

Medac Gesellschaft Fur Klinische Spezialpraparate Mbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Medac Gesellschaft Fur Klinische Spezialpraparate Mbh

Patent Number:
EP2478907
Title:
Methods And Compositions For Treating Cancer
Applicant:
COUGAR BIOTECHNOLOGY, INC.
Opposition Date:
Jan 11, 2022
Patent Number:
EP2493466
Title:
Novel Antitumoral Use Of Cabazitaxel
Applicant:
AVENTIS PHARMA S.A.
Opposition Date:
Mar 22, 2021
Patent Number:
EP3294285
Title:
Cabazitaxel And Its Use For Treating Cancer
Applicant:
AVENTIS PHARMA S.A.
Opposition Date:
Sep 18, 2020

Competitors of Medac Gesellschaft Fur Klinische Spezialpraparate Mbh

AVENTIS PHARMA S.A.

SANOFI MATURE IP

COUGAR BIOTECHNOLOGY, INC.

Want to track Medac Gesellschaft Fur Klinische Spezialpraparate Mbh?

Feel free to send us a message here and we will get back to you